Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACTIC-CKD
NCT07911124Phase 2Not yet recruiting
- Sponsor
- University of Arkansas
- Start
- Nov 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
A Phase 2 trial of ticagrelor in chronic kidney disease (CKD), sponsored by University of Arkansas. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ticagrelor
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07911124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07911124.